CN112602781A - Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof - Google Patents

Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof Download PDF

Info

Publication number
CN112602781A
CN112602781A CN202011569955.0A CN202011569955A CN112602781A CN 112602781 A CN112602781 A CN 112602781A CN 202011569955 A CN202011569955 A CN 202011569955A CN 112602781 A CN112602781 A CN 112602781A
Authority
CN
China
Prior art keywords
powder
milk powder
formula
hyperglycemia
whey protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011569955.0A
Other languages
Chinese (zh)
Inventor
梁红波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Jinhuiyuan Agricultural Technology Co ltd
Original Assignee
Sichuan Jinhuiyuan Agricultural Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Jinhuiyuan Agricultural Technology Co ltd filed Critical Sichuan Jinhuiyuan Agricultural Technology Co ltd
Priority to CN202011569955.0A priority Critical patent/CN112602781A/en
Publication of CN112602781A publication Critical patent/CN112602781A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00Whey; Whey preparations
    • A23C21/06Mixtures of whey with milk products or milk components
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00Whey; Whey preparations
    • A23C21/02Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00Whey; Whey preparations
    • A23C21/04Whey; Whey preparations containing non-milk components as source of fats or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00Whey; Whey preparations
    • A23C21/08Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight: 30-70% of milk powder, 0-40% of desalted whey powder, 0-15% of linseed oil powder, 0-3% of fish oil powder, 0-10% of maltodextrin, 0-15% of whey protein powder, 0-5% of soybean peptide, 0-5% of corn peptide, 0-5% of resistant dextrin, 0-5% of inulin, 0-5% of fructo-oligosaccharide, 0-1% of phytosterol ester, 0-2% of selenium-enriched yeast, 0.1-0.8% of catechin, 0.1-0.5% of tea theanine, 0-0.1% of lactoferrin, 0-0.3% of cubilose acid, 0-1% of yeast beta-glucan, 2-5% of oat beta-glucan and 0-1% of probiotics, and the balance of other additives. The invention also discloses a preparation method of the milk powder formula which is helpful for reducing and preventing the three highs.

Description

Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof
Technical Field
The invention belongs to the field of milk powder preparation, and particularly relates to a formula of milk powder for reducing and preventing hypertension, hyperlipidemia and hyperglycemia and a preparation method thereof.
Background
At present, many milk powders in the market have high sugar content, or the milk source quality is not guaranteed, and the content of nutrients is not high, so that the milk powders are not suitable for people suffering from 'three high'. The people with high blood pressure, high blood sugar and high blood sugar are mostly caused by other intermediate primary diseases such as genetic factors, dietary factors, work and rest factors and the like. Most of the existing adult milk powder in the market is prepared by adding auxiliary materials into raw milk and milk powder, such as: the milk powder is produced by spraying and physically mixing vegetable oil, lactose, maltodextrin, desalted whey powder, cane sugar, prebiotics, probiotic vitamins, mineral substances and the like, and whether the nutritional structure of the product is suitable for people with high blood pressure, high blood sugar and high blood sugar is not considered. The existing products mainly aim at providing nutrition support for users, supplementing mineral elements, improving intestinal function or body resistance, and are not directly designed for the 'three-high people'. Other products for reducing and preventing hypertension, hyperglycemia and hyperlipidemia are mainly medicaments, health-care foods, solid beverage oral liquid and the like.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a formula of milk powder for reducing and preventing hypertension, hyperglycemia and hyperlipidemia and a preparation method thereof, aiming at overcoming the defects of the prior art.
The technical scheme adopted by the invention is as follows: the formula of the milk powder helpful for reducing and preventing the three highs comprises the following components in percentage by weight:
30-70% of milk powder, 0-40% of desalted whey powder, 0-15% of linseed oil powder, 0-3% of fish oil powder, 0-10% of maltodextrin, 0-15% of whey protein powder, 0-5% of soybean peptide, 0-5% of corn peptide, 0-5% of resistant dextrin, 0-5% of inulin, 0-5% of fructo-oligosaccharide, 0-1% of phytosterol ester, 0-2% of selenium-enriched yeast, 0.1-0.8% of catechin, 0.1-0.5% of tea theanine, 0-0.1% of lactoferrin, 0-0.3% of cubilose acid, 0-1% of yeast beta-glucan, 2-5% of oat beta-glucan and 0-1% of probiotics, and the balance of other additives.
In one embodiment, the milk powder comprises at least one of skimmed milk powder, whole milk powder and whole goat milk powder, wherein the skimmed milk powder accounts for 20-70 wt%, the whole milk powder accounts for 10-50 wt%, and the whole goat milk powder accounts for 0-50 wt%.
In one embodiment, the whey protein powder comprises at least one of concentrated whey protein powder and separated whey protein powder, wherein the concentrated whey protein powder accounts for 0-10 wt%, and the separated whey protein powder accounts for 0-5 wt%.
In one embodiment, the paint comprises the following components in percentage by weight:
57% of milk powder, 10% of desalted whey powder, 10% of linseed oil powder, 1% of fish oil powder, 1.5% of maltodextrin, 5% of whey protein, 1% of soybean peptide, 1% of corn peptide, 2% of resistant dextrin, 2% of inulin, 2% of fructo-oligosaccharide, 1% of phytosterol ester, 0.1% of selenium-enriched yeast, 0.65% of catechin, 0.3% of tea theanine, 5% of oat beta-glucan and the balance of other additives.
In one embodiment, the milk powder comprises 40% of skimmed milk powder and 17% of full-fat milk powder.
In one embodiment, the whey protein powder comprises 5% concentrated whey protein powder.
The invention also discloses a preparation method of the milk powder formula for reducing and preventing the three highs, which comprises the following steps:
step 10, unpacking and sterilizing: performing unpacking sterilization on the raw materials, wiping the inner package with 75% alcohol after unpacking, and sterilizing with ultraviolet light for later use;
step 20, screening: screening the raw materials subjected to unpacking sterilization in the step 10, and removing large particles and impurities in the raw materials to obtain a formula material;
step 30, batching: weighing the formula materials screened in the step 20 according to the formula proportion for later use, wherein the environmental temperature is 20-25 ℃ and the environmental humidity is 45-65% in the weighing process;
step 40, premixing: premixing fish oil, maltodextrin, soybean peptide, corn peptide, resistant dextrin, inulin, fructo-oligosaccharide, phytosterol ester, selenium-enriched yeast, catechin, theanine, oat beta glucan and a nutrition enhancer to obtain a premix;
step 40, mixing: and (3) adding milk powder, desalted whey powder, whey protein powder, linseed oil powder and the premix obtained in the step (40) in sequence, mixing, wherein the adding interval of the two formula materials is 3-5 minutes in the mixing process, and continuously mixing for 30-35 minutes after the formula materials are added to obtain the milk powder formula which is beneficial to reducing and preventing hypertension, hyperlipidemia and hyperglycemia.
In one embodiment, in step 20, the screen mesh used for screening has a mesh size of 30-60 mesh.
In one embodiment, in step 30, the ambient temperature is 22 ℃ and the ambient humidity is 50% during the weighing process.
In one embodiment, the time interval between the two formula materials is 4 minutes during the mixing process, and the mixing time is 32 minutes after the formula materials are added.
The invention has the beneficial effects that: the milk powder (whole milk powder, skim milk powder and desalted whey powder) is used as a main raw material, and auxiliary materials such as flax oil powder, small molecular peptides (soybean peptide and corn peptide), dietary fibers (resistant dextrin, fructo-oligosaccharide and inulin), beta-glucan and maltodextrin are used as auxiliary materials, and substances such as fish oil powder, theanine, phytosterol ester, catechin and selenium-enriched yeast which are helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia are added, so that the milk powder is helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia on the premise of ensuring the quality and nutritional requirements of common milk powder.
Detailed Description
The present invention will be described in further detail with reference to specific examples.
Example 1:
the invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight:
30-70% of milk powder, 0-40% of desalted whey powder, 0-15% of linseed oil powder, 0-3% of fish oil powder, 0-10% of maltodextrin, 0-15% of whey protein powder, 0-5% of soybean peptide, 0-5% of corn peptide, 0-5% of resistant dextrin, 0-5% of inulin, 0-5% of fructo-oligosaccharide, 0-1% of phytosterol ester, 0-2% of selenium-enriched yeast, 0.1-0.8% of catechin, 0.1-0.5% of tea theanine, 0-0.1% of lactoferrin, 0-0.3% of cubilose acid, 0-1% of yeast beta-glucan, 2-5% of oat beta-glucan and 0-1% of probiotics, and the balance of other additives.
The names and the amounts of the specific components in this example are shown in table 1:
table 1: example 1 component name and usage Scale
Figure BDA0002862162240000041
Figure BDA0002862162240000051
Example 2:
the invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight:
20-70% of skimmed milk powder, 10-50% of whole milk powder, 0-50% of whole goat milk powder, 0-40% of desalted whey powder, 0-15% of flaxseed oil powder, 0-3% of fish oil powder, 0-10% of maltodextrin, 0-15% of whey protein powder, 0-5% of soybean peptide, 0-5% of corn peptide and 0-5% of resistant dextrin, 0-5% of inulin, 0-5% of fructo-oligosaccharide, 0-1% of phytosterol ester, 0-2% of selenium-enriched yeast, 0.1-0.8% of catechin, 0.1-0.5% of tea theanine, 0-0.1% of lactoferrin, 0-0.3% of cubilose acid, 0-1% of yeast beta-glucan, 2-5% of oat beta-glucan, 0-1% of probiotics and the balance of other additives.
The names and the amounts of the specific components in this example are shown in table 2:
table 2: example 2 component names and usage tables
Figure BDA0002862162240000061
Figure BDA0002862162240000071
Example 3:
the invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight:
30-70% of milk powder, 0-40% of desalted whey powder, 0-15% of linseed oil powder, 0-3% of fish oil powder, 0-10% of maltodextrin, 0-10% of concentrated whey protein powder, 0-5% of separated whey protein powder, 0-5% of soybean peptide, 0-5% of corn peptide, 0-5% of resistant dextrin, 0-5% of inulin, 0-5% of fructo-oligosaccharide, 0-1% of phytosterol ester, 0-2% of selenium-enriched yeast, 0.1-0.8% of catechin, 0.1-0.5% of tea theanine, 0-0.1% of lactoferrin, 0-0.3% of cubilose acid, 0-1% of yeast beta-glucan, 2-5% of oat beta-glucan, 0-1% of probiotics and the balance of other additives.
The names and the amounts of the specific components in this example are shown in table 3:
table 3: example 3 component name and usage Scale
Figure BDA0002862162240000072
Figure BDA0002862162240000081
Example 4:
the invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight:
57% of milk powder, 10% of desalted whey powder, 10% of linseed oil powder, 1% of fish oil powder, 1.5% of maltodextrin, 5% of whey protein, 1% of soybean peptide, 1% of corn peptide, 2% of resistant dextrin, 2% of inulin, 2% of fructo-oligosaccharide, 1% of phytosterol ester, 0.1% of selenium-enriched yeast, 0.65% of catechin, 0.3% of tea theanine, 5% of oat beta-glucan and the balance of other additives.
The names and the amounts of the specific components in this example are shown in table 4:
table 4: example 4 component name and usage Scale
Figure BDA0002862162240000091
Figure BDA0002862162240000101
Example 5:
the invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight:
40% of skim milk powder, 17% of full-cream milk powder, 10% of desalted whey powder, 10% of linseed oil powder, 1% of fish oil powder, 1.5% of maltodextrin, 5% of whey protein, 1% of soybean peptide, 1% of corn peptide, 2% of resistant dextrin, 2% of inulin, 2% of fructo-oligosaccharide, 1% of phytosterol ester, 0.1% of selenium-enriched yeast, 0.65% of catechin, 0.3% of tea theanine and 5% of oat beta-glucan, and the balance of other additives.
The names and the amounts of the specific components in this example are shown in table 5:
table 5: example 5 component name and usage Scale
Figure BDA0002862162240000102
Figure BDA0002862162240000111
Example 6:
the invention discloses a milk powder formula helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in percentage by weight:
57% of milk powder, 10% of desalted whey powder, 10% of linseed oil powder, 1% of fish oil powder, 1.5% of maltodextrin, 5% of concentrated whey protein, 1% of soybean peptide, 1% of corn peptide, 2% of resistant dextrin, 2% of inulin, 2% of fructo-oligosaccharide, 1% of phytosterol ester, 0.1% of selenium-enriched yeast, 0.65% of catechin, 0.3% of tea theanine and 5% of oat beta-glucan, and the balance of other additives.
The names and the amounts of the specific components in this example are shown in Table 6:
table 6: example 6 component name and usage Scale
Figure BDA0002862162240000112
Figure BDA0002862162240000121
In the six embodiments, the invention also discloses a preparation method of the milk powder formula for reducing and preventing hypertension, hyperlipidemia and hyperglycemia, which comprises the following steps:
step 10, unpacking and sterilizing: performing unpacking sterilization on the raw materials, wiping the inner package with 75% alcohol after unpacking, and sterilizing with ultraviolet light for later use;
step 20, screening: screening the raw materials subjected to unpacking sterilization in the step 10, and removing large particles and impurities in the raw materials to obtain a formula material;
step 30, batching: weighing the formula materials screened in the step 20 according to the formula proportion for later use, wherein the environmental temperature is 20-25 ℃ and the environmental humidity is 45-65% in the weighing process;
step 40, premixing: premixing fish oil, maltodextrin, soybean peptide, corn peptide, resistant dextrin, inulin, fructo-oligosaccharide, phytosterol ester, selenium-enriched yeast, catechin, theanine, oat beta glucan and a nutrition enhancer to obtain a premix;
step 40, mixing: and (3) adding milk powder, desalted whey powder, whey protein powder, linseed oil powder and the premix obtained in the step (40) in sequence, mixing, wherein the adding interval of the two formula materials is 3-5 minutes in the mixing process, and continuously mixing for 30-35 minutes after the formula materials are added to obtain the milk powder formula which is beneficial to reducing and preventing hypertension, hyperlipidemia and hyperglycemia.
In this embodiment, in step 20, the screen mesh used for screening has a pore size of 30 to 60 mesh.
In this embodiment, in step 30, the ambient temperature is 22 ℃ and the ambient humidity is 50% during the weighing process.
In the embodiment, in the mixing process, the adding interval time of the two formula materials is 4 minutes, and after the formula materials are added, the mixing time is continued for 32 minutes.
The formula of the milk powder disclosed in the embodiment takes the national standard GB19644 as a product execution standard, and the finished product is white or light yellow powder and has certain fragrance. And adding other additives according to the related requirements and national standards. The other additives are composite nutrition enhancers in the conventional case, and the percentage of the additives is 0.45 percent. The protein content of the formula of the milk powder disclosed in the above embodiment is 20.1g/100g, and the formula comprises the following components: milk proteins, soy peptides, corn peptides; the fat content is 11.0g/100g, and the fat comprises the following components: milk fat, linseed oil, fish oil; the dietary fiber is 6g/100g, and comprises the following components: resistant dextrin, fructo-oligosaccharide, inulin.
The invention takes milk powder (whole milk powder, skim milk powder and desalted whey powder) as main raw materials, flax oil powder, small molecular peptides (soybean peptide and corn peptide), dietary fibers (resistant dextrin, fructo-oligosaccharide, inulin), beta-glucan, maltodextrin and other auxiliary materials as auxiliary materials, and fish oil powder, theanine, phytosterol ester, catechin, selenium-enriched yeast and other substances which are helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia are added, and the invention is helpful for reducing and preventing hypertension, hyperglycemia and hyperlipidemia on the premise of ensuring the quality and nutritional requirements of common milk powder.
The above-mentioned embodiments only express the specific embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the present invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention.

Claims (10)

1. The formula of the milk powder helpful for reducing and preventing the three highs is characterized by comprising the following components in percentage by weight:
30-70% of milk powder, 0-40% of desalted whey powder, 0-15% of linseed oil powder, 0-3% of fish oil powder, 0-10% of maltodextrin, 0-15% of whey protein powder, 0-5% of soybean peptide, 0-5% of corn peptide, 0-5% of resistant dextrin, 0-5% of inulin, 0-5% of fructo-oligosaccharide, 0-1% of phytosterol ester, 0-2% of selenium-enriched yeast, 0.1-0.8% of catechin, 0.1-0.5% of tea theanine, 0-0.1% of lactoferrin, 0-0.3% of cubilose acid, 0-1% of yeast beta-glucan, 2-5% of oat beta-glucan and 0-1% of probiotics, and the balance of other additives.
2. The milk powder formula for helping to reduce and prevent hyperlipidemia, hyperglycemia and hyperglycemia as claimed in claim 1, wherein the milk powder comprises at least one of skimmed milk powder, whole milk powder and whole goat milk powder, wherein the skimmed milk powder is 20-70% by weight, the whole milk powder is 10-50% by weight, and the whole goat milk powder is 0-50% by weight.
3. The milk powder formula helpful for reducing and preventing hyperlipidemia, hyperglycemia and hyperglycemia as claimed in claim 1 or 2, wherein the whey protein powder comprises at least one of concentrated whey protein powder and isolated whey protein powder, wherein the concentrated whey protein powder is 0-10% by weight, and the isolated whey protein powder is 0-5% by weight.
4. The milk powder formula for helping to reduce and prevent the hypertension, the hyperglycemia and the hyperlipidemia as well as the hyperlipidemia as described in claim 3 is characterized by comprising the following components in percentage by weight:
57% of milk powder, 10% of desalted whey powder, 10% of linseed oil powder, 1% of fish oil powder, 1.5% of maltodextrin, 5% of whey protein, 1% of soybean peptide, 1% of corn peptide, 2% of resistant dextrin, 2% of inulin, 2% of fructo-oligosaccharide, 1% of phytosterol ester, 0.1% of selenium-enriched yeast, 0.65% of catechin, 0.3% of tea theanine, 5% of oat beta-glucan and the balance of other additives.
5. The formula of milk powder for reducing and preventing hyperlipidemia, hyperglycemia and hyperglycemia as claimed in claim 4, wherein the milk powder comprises 40% of skimmed milk powder and 17% of whole milk powder.
6. The milk powder formula for helping to reduce and prevent hyperlipidemia and hyperglycemia as claimed in claim 5, wherein the whey protein powder comprises 5% concentrated whey protein powder.
7. A preparation method of a milk powder formula for helping to reduce and prevent three highs is characterized by comprising the following steps:
step 10, unpacking and sterilizing: performing unpacking sterilization on the raw materials, wiping the inner package with 75% alcohol after unpacking, and sterilizing with ultraviolet light for later use;
step 20, screening: screening the raw materials subjected to unpacking sterilization in the step 10, and removing large particles and impurities in the raw materials to obtain a formula material;
step 30, batching: weighing the formula materials screened in the step 20 according to the formula proportion for later use, wherein the environmental temperature is 20-25 ℃ and the environmental humidity is 45-65% in the weighing process;
step 40, premixing: premixing fish oil, maltodextrin, soybean peptide, corn peptide, resistant dextrin, inulin, fructo-oligosaccharide, phytosterol ester, selenium-enriched yeast, catechin, theanine, oat beta glucan and a nutrition enhancer to obtain a premix;
step 40, mixing: and (3) adding milk powder, desalted whey powder, whey protein powder, linseed oil powder and the premix obtained in the step (40) in sequence, mixing, wherein the adding interval of the two formula materials is 3-5 minutes in the mixing process, and continuously mixing for 30-35 minutes after the formula materials are added to obtain the milk powder formula which is beneficial to reducing and preventing hypertension, hyperlipidemia and hyperglycemia.
8. The method of claim 7, wherein the size of the screen mesh used in the step 20 is 30-60 mesh.
9. The method of claim 7, wherein the ambient temperature and humidity during weighing is 22 ℃ and 50% respectively.
10. The method of claim 7 wherein the two formula ingredients are added at an interval of 4 minutes during the mixing process and the mixing is continued for 32 minutes after the formula ingredients are added.
CN202011569955.0A 2020-12-26 2020-12-26 Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof Pending CN112602781A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011569955.0A CN112602781A (en) 2020-12-26 2020-12-26 Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011569955.0A CN112602781A (en) 2020-12-26 2020-12-26 Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112602781A true CN112602781A (en) 2021-04-06

Family

ID=75248142

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011569955.0A Pending CN112602781A (en) 2020-12-26 2020-12-26 Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112602781A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113154851A (en) * 2021-05-07 2021-07-23 湖南康琪壹佰生物科技有限公司 Health food capable of conditioning blood fat, blood sugar and blood pressure and preparation method thereof
CN113170822A (en) * 2021-05-19 2021-07-27 许展旭 Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof
CN113812464A (en) * 2021-08-10 2021-12-21 美庐生物科技股份有限公司 Formula of milk powder helpful for preventing hypertension, hyperglycemia and hyperlipidemia of middle-aged and old people and preparation method of milk powder
CN114158619A (en) * 2021-12-13 2022-03-11 周云一 A nutritious milk powder with health promoting effects for reducing blood pressure, blood lipid and blood sugar, and resisting cancer
CN114504028A (en) * 2022-02-24 2022-05-17 甘肃华羚乳品股份有限公司 Buttered tea beverage suitable for people with high blood pressure, high blood sugar and high blood sugar
CN114617168A (en) * 2022-03-30 2022-06-14 四川金汇源农业科技有限责任公司 Milk powder formula suitable for lactose intolerant people and preparation method thereof
CN114651873A (en) * 2022-02-22 2022-06-24 黑龙江益得莱乳业科技有限公司 Health-care modified milk powder assisting in reducing high blood pressure, high blood sugar and low blood Glucose (GI) and preparation method thereof
JP7146028B1 (en) * 2021-06-24 2022-10-03 森永乳業株式会社 nutritional composition
CN115486482A (en) * 2021-06-23 2022-12-20 临夏州燎原乳业有限公司 Yak formula milk powder beneficial to cardiovascular health
CN116508849A (en) * 2023-02-20 2023-08-01 西北农林科技大学 Formula goat milk powder, preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104798908A (en) * 2015-05-08 2015-07-29 陕西雅泰乳业有限公司 Zinc-rich formula goat milk powder and preparation method thereof
CN106036842A (en) * 2016-05-31 2016-10-26 安徽皖斛堂生物科技有限公司 Health-care instant powder for people suffering from hyperlipidemia, hypertension and hyperglycemia and preparation method of health-care instant powder
CN111184072A (en) * 2020-03-02 2020-05-22 上海育博营养食品有限公司 Milk powder beneficial to enhancing immunity and improving resistance and production method thereof
CN111713690A (en) * 2020-06-26 2020-09-29 上海复旦奥医医学科技有限公司 Special medical nutrition formula food for alopecia and preparation method thereof
CN112042757A (en) * 2020-09-15 2020-12-08 四川金汇源农业科技有限责任公司 Milk powder formula beneficial to improving sleep and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104798908A (en) * 2015-05-08 2015-07-29 陕西雅泰乳业有限公司 Zinc-rich formula goat milk powder and preparation method thereof
CN106036842A (en) * 2016-05-31 2016-10-26 安徽皖斛堂生物科技有限公司 Health-care instant powder for people suffering from hyperlipidemia, hypertension and hyperglycemia and preparation method of health-care instant powder
CN111184072A (en) * 2020-03-02 2020-05-22 上海育博营养食品有限公司 Milk powder beneficial to enhancing immunity and improving resistance and production method thereof
CN111713690A (en) * 2020-06-26 2020-09-29 上海复旦奥医医学科技有限公司 Special medical nutrition formula food for alopecia and preparation method thereof
CN112042757A (en) * 2020-09-15 2020-12-08 四川金汇源农业科技有限责任公司 Milk powder formula beneficial to improving sleep and preparation method thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113154851A (en) * 2021-05-07 2021-07-23 湖南康琪壹佰生物科技有限公司 Health food capable of conditioning blood fat, blood sugar and blood pressure and preparation method thereof
CN113154851B (en) * 2021-05-07 2022-07-22 湖南康琪壹佰生物科技有限公司 Health food capable of conditioning blood fat, blood sugar and blood pressure and preparation method thereof
CN113170822A (en) * 2021-05-19 2021-07-27 许展旭 Low-fat goat milk powder for preventing and reducing hypertension, hyperglycemia and hyperlipidemia of middle-aged and elderly people and preparation method thereof
CN115486482A (en) * 2021-06-23 2022-12-20 临夏州燎原乳业有限公司 Yak formula milk powder beneficial to cardiovascular health
JP7146028B1 (en) * 2021-06-24 2022-10-03 森永乳業株式会社 nutritional composition
WO2022270065A1 (en) * 2021-06-24 2022-12-29 森永乳業株式会社 Nutritional composition
CN113812464A (en) * 2021-08-10 2021-12-21 美庐生物科技股份有限公司 Formula of milk powder helpful for preventing hypertension, hyperglycemia and hyperlipidemia of middle-aged and old people and preparation method of milk powder
CN114158619A (en) * 2021-12-13 2022-03-11 周云一 A nutritious milk powder with health promoting effects for reducing blood pressure, blood lipid and blood sugar, and resisting cancer
CN114651873A (en) * 2022-02-22 2022-06-24 黑龙江益得莱乳业科技有限公司 Health-care modified milk powder assisting in reducing high blood pressure, high blood sugar and low blood Glucose (GI) and preparation method thereof
CN114504028A (en) * 2022-02-24 2022-05-17 甘肃华羚乳品股份有限公司 Buttered tea beverage suitable for people with high blood pressure, high blood sugar and high blood sugar
CN114617168A (en) * 2022-03-30 2022-06-14 四川金汇源农业科技有限责任公司 Milk powder formula suitable for lactose intolerant people and preparation method thereof
CN116508849A (en) * 2023-02-20 2023-08-01 西北农林科技大学 Formula goat milk powder, preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN112602781A (en) Formula of milk powder helpful for reducing and preventing three highs and preparation method thereof
KR100651703B1 (en) Tablet milk composition having immuno-modulating activity and preparation method thereof
CN112042757A (en) Milk powder formula beneficial to improving sleep and preparation method thereof
Autret et al. Possible sources of proteins for child feeding in underdeveloped countries
JP2019528060A (en) Process for producing beverages or beverage ingredients from beer lees
CN104146300B (en) Compound Noni puree and preparation method thereof
WO2020122435A1 (en) Rice milk employing rice protein and manufacturing method therefor
KR101405372B1 (en) Composition for diet containing soybean peptide
Taylor et al. Sorghum flour and flour products: Production, nutritional quality, and fortification
US20240114925A1 (en) Nutritional compositions from brewers' spent grain and methods for making the same
CN107712874A (en) Depth hydrolysis' protein prescription powder and technique manufacturing method
WO2020247363A1 (en) Nutritional compositions from brewers' spent grain and methods for making the same
CN111374264A (en) Oat dietary fiber powder and preparation method thereof
CN103598387B (en) Zinc-supplementation chocolate for children
KR20220095717A (en) Health functional food for diet and method for preparing the same
CN110973424A (en) Ginseng micromolecule peptide solid beverage and preparation method thereof
CN106173853B (en) Nutritional composition for reducing blood fat and application thereof
CN1244295C (en) Fermented maize germ beverage and its production method
CN109090335A (en) A kind of bitter-buckwheat nutritive product, bitter buckwheat albumen powder and its extraction process
CN100544609C (en) A kind of emulsification predigestion rice protein and its production and application
CN114946951A (en) Milk powder capable of preventing and improving three highs and preparation method thereof
KR20160057260A (en) Cake containing yacon powder and method for manufacturing the same
CN114617168A (en) Milk powder formula suitable for lactose intolerant people and preparation method thereof
CN108967702A (en) A kind of piglet special forage formula
KR101461663B1 (en) A method of processing multigrain and convenience foods using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination